Abbott s new global diagnostics coalition focuses on future pandemic preparedness
Abbott s new global diagnostics coalition focuses on future pandemic preparedness
Kelsy Ketchum, 360Dx
Print
Although the pandemic isn t over yet, the question of future pandemics is still on the mind of many infectious disease experts.
With that in mind, Abbott is using its infectious disease experience, building on its Global Viral Surveillance Program for HIV and viral hepatitis research, to spearhead a coalition that will prepare for disease outbreaks, particularly those that haven t yet happened and pathogens that have yet to be discovered.
According to Gavin Cloherty, the head of infectious disease research at Abbott, the Abbott Pandemic Defense Coalition is the culmination of several years of preparation that has grown from the global surveillance program.
Rush Partners With Abbott To Prepare For Future Pandemics
Rush is first partner in the U.S. to join the Global Pandemic Defense Coalition
News provided by
Share this article
Share this article
CHICAGO, March 16, 2021 /PRNewswire/ Rush University Medical Center is the first partner in the United States in the Abbott Pandemic Defense Coalition, an effort led by Abbott to detect future pathogen outbreaks that could become pandemics. This first-of-its-kind scientific network is enlisting partners around the world to provide laboratory testing, genetic sequencing and public health research to analyze the potential risk level of newly identified pathogens, develop new diagnostic testing and understand the public health impact of the pathogens identified in real time.
Abbott has announced its Pandemic Defense Coalition selectscience.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from selectscience.net Daily Mail and Mail on Sunday newspapers.
NORTH CHICAGO (dpa-AFX) - Abbott (ABT) said that it has formed Abbott Pandemic Defense Coalition, which is a first-of-its-kind global scientific network dedicated to the early detection of, and
Mar 11, 2021 12:14pm Abbott previously launched its Global Viral Surveillance Program over 25 years ago to monitor HIV and hepatitis; that program will be folded into the new pandemic coalition. (NIAID - Rocky Mountain Laboratories)
A year into this global pandemic, Abbott is preparing for the next one: the medtech giant has launched a network of centers with expertise in lab testing, genetic sequencing and public health to help catch and track emerging viruses and potentially dangerous mutations.
The goal of the company’s Pandemic Defense Coalition is to help develop diagnostic tests quickly as new threats are discovered and to publish their sequencing findings publicly so others can help determine if the disease is a novel strain.